November 2025

glaucoma-eye-problem

Stem Cells Show Promise in Restoring Vision in AMD Patients

For millions of people around the world, a diagnosis of age-related macular degeneration (AMD) has meant the irreversible loss of central vision. This condition, which blurs the sharp, central vision needed for activities like reading and driving, has long been considered a one-way path. However, a groundbreaking new development is challenging that long-held belief. The

Stem Cells Show Promise in Restoring Vision in AMD Patients Read More »

TearOptix secures funding for presbyopia MF lens tech

TearOptix Secures Funding for Innovative Presbyopia Lens Technology The world of vision correction is on the verge of a significant breakthrough. For the millions of adults experiencing the frustrating blur of presbyopia—the age-related loss of near vision—a new, non-surgical solution is emerging. In a major vote of confidence for this innovative approach, TearOptix has successfully

TearOptix secures funding for presbyopia MF lens tech Read More »

glaucoma-eye-problem

Dallas Eye Surgeon’s Journey from Gaza to Entrepreneurship

Dr. Tarek Sabti’s story is not a conventional one. It’s a narrative that weaves together the precision of an ophthalmologist, the resilience of a refugee, and the bold vision of an entrepreneur. His journey, which began amidst the turmoil of Gaza and culminated in the heart of the Dallas medical community, is a powerful testament

Dallas Eye Surgeon’s Journey from Gaza to Entrepreneurship Read More »

glaucoma-eye-problem

PhilHealth’s New Guidelines Transform Eye Care Services

For millions of Filipinos, clear vision is not just a matter of convenience—it is a gateway to education, livelihood, and an improved quality of life. Recognizing this, the Philippine Health Insurance Corporation (PhilHealth) has taken a monumental step forward. The recent unveiling of its new guidelines for eye care services marks a significant shift in

PhilHealth’s New Guidelines Transform Eye Care Services Read More »

Scroll to Top